HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
14.04
-0.18 (-1.27%)
At close: Dec 8, 2025, 4:00 PM EST
14.10
+0.06 (0.43%)
After-hours: Dec 8, 2025, 4:10 PM EST
HUTCHMED (China) Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HUTCHMED (China) stock has a target of 13.75, which predicts a -2.07% decrease from the current stock price of 14.04.
Price Target: $13.75 (-2.07%)
Analyst Consensus: Sell
* Price targets were last updated on Sep 22, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for HUTCHMED (China) is "Sell". This means that the analyst believes this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold → Sell Downgrades $18 → $14 | Hold → Sell | Downgrades | $18 → $14 | -2.07% | Sep 22, 2025 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $17 → $19 | Hold | Maintains | $17 → $19 | +35.33% | Aug 1, 2024 |
| Deutsche Bank | Deutsche Bank | Hold → Strong Buy Upgrades $20 → $22 | Hold → Strong Buy | Upgrades | $20 → $22 | +57.41% | Nov 24, 2023 |
| Goldman Sachs | Goldman Sachs | Hold Maintains $15 → $17 | Hold | Maintains | $15 → $17 | +21.08% | Nov 10, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $50 | Buy | Reiterates | $50 | +256.13% | Sep 5, 2023 |
Financial Forecast
Revenue This Year
611.75M
from 630.20M
Decreased by -2.93%
Revenue Next Year
706.82M
from 611.75M
Increased by 15.54%
EPS This Year
0.51
from 0.04
Increased by 1,176.36%
EPS Next Year
0.08
from 0.51
Decreased by -83.85%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 692.7M | 863.0M | ||||
| Avg | 611.8M | 706.8M | ||||
| Low | 522.3M | 586.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.9% | 41.1% | ||||
| Avg | -2.9% | 15.5% | ||||
| Low | -17.1% | -4.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.65 | 0.19 | ||
| Avg | 0.51 | 0.08 | ||
| Low | 0.41 | 0.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1,527.5% | -63.4% | ||
| Avg | 1,176.4% | -83.9% | ||
| Low | 922.1% | -96.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.